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Abstract
Objective: In this retrospective study, patients’ medical records were reviewed to investigate the profiles of 633 
OLP cases in a group of Romania.
Material and Methods: In this retrospective study, the following clinical data were obtained from the medical 
charts of patients: gender, age, clinical presentation of OLP, site affected, presence of symptoms, extraoral mani-
festations of lichen planus, presence of systemic diseases, and history of medications. 
Results: Most (78.67%) OLP patients were female and the mean age at presentation was 52 years. The white type 
of the disease (reticular/papular/plaque lesions) was the main form encountered in this sample (48.97%). Among 
patients with available hepatitis C virus test results, 9.6% were serum-positive. OLP was associated with gallblad-
der disease (i.e. cholecystitis, cholelithiasis) in 19% of patients. Six patients (0.95%) developed squamous cell 
carcinoma at a site with confirmed OLP lesions.
Conclusions: To the best of our knowledge, no similar study has been conducted in a Romanian population. The 
present investigation revealed the predominance of OLP among middle-aged white women and the prevalence of 
bilateral involvement of the buccal mucosa with reticular white lesions. Anti-HCV circulating antibodies were 
more common in patients with OLP than in the general population and, notably, OLP was associated with gall-
bladder disease (cholecystitis, cholelithiasis) in 19% of patients.
Key words: Oral lichen planus, oral mucosal diseases, retrospective study.
Tovaru S, Parlatescu I, Gheorghe C, Tovaru M, Costache M, Sardella A. 
Oral lichen planus: A retrospective study of 633 patients from Bucharest, 
Romania. Med Oral Patol Oral Cir Bucal. 2013 Mar 1;18 (2):e201-6. 
http://www.medicinaoral.com/medoralfree01/v18i2/medoralv18i2p201.pdf
Article Number: 18035          http://www.medicinaoral.com/
© Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946
eMail:  medicina@medicinaoral.com 
Indexed in: 
Science Citation Index Expanded
Journal Citation Reports
Index Medicus, MEDLINE, PubMed
Scopus, Embase and Emcare 
Indice Médico Español
doi:10.4317/medoral.18035
http://dx.doi.org/doi:10.4317/medoral.18035
Med Oral Patol Oral Cir Bucal. 2013 Mar 1;18 (2):e201-6.                                                                                                                                                                      Oral lichen planus in Bucharest
e202
Introduction
Oral lichen planus (OLP) is a chronic inflammatory dis-
ease that affects stratified squamous epithelium. Sever-
al immunological mechanisms of its pathogenesis have 
been proposed, including antigen-specific cell-mediated 
immune response, non-specific immunological mecha-
nisms, autoimmune response, and humoural immunity 
(1). The estimated prevalence of the disease in the gener-
al population is 1–1.5% (2), with a predominance among 
females in the fifth and sixth decades of life. About 15–
20% of patients with OLP have or develop skin lesions 
(3), typically manifesting as erythematous and itchy flat 
papules on the flexor surfaces of the forearms. Other 
mucosal sites may be involved, including the genitalia, 
oesophagus, larynx, and conjunctiva (4). The clinical 
features of OLP are generally polymorphic and usually 
consist of bilateral and/or multiple symmetrical lesions, 
such as white and raised papules or plaques, erosions, 
or often-painful atrophic lesions (4). Although evidence 
for the necessity of histological evaluation is not defini-
tive and inter- and intra-observer variability are often 
high (5), on biopsy OLP shows basal layer destruction 
and basal membrane interruption due to hydropic de-
generation, the apoptosis-related formation of Civatte 
bodies, and a juxta-epithelial lymphocyte inflammatory 
infiltrate with a band arrangement (6). OLP has been 
associated with a risk of malignant transformation that 
has ranged from 0.4–5% over 0.5–20-year periods of 
observation (7).
Several epidemiological studies in various parts of the 
world have described the clinical characteristics of OLP. 
However, few studies have examined OLP in Eastern 
Europe. The purpose of this study was to describe the 
clinical characteristics and associated systemic diseases 
of OLP in 633 Romanian patients.
Material and Methods
An observational and retrospective study was con-
ducted at the Department of Oral Medicine and Oral 
Pathology, Faculty of Dental Medicine, Carol Davila 
University, Bucharest, Romania. A total of 889 medical 
charts of patients diagnosed with OLP between Janu-
ary 1990 and September 2010 were analysed by two 
experienced oral physicians (ST, AS) and an experi-
enced oral pathologist (MC). The Bioethics Committee 
of the University Carol Davila was informed about the 
retrospective evaluation process on medical charts. The 
following clinical data were obtained from the medical 
charts: gender, age, clinical presentation of OLP, site af-
fected, presence of symptoms, extraoral manifestations 
of lichen planus, presence of systemic diseases, and his-
tory of medications. Major stressful events (e.g. death 
of family member, divorce, job loss, major accident) 
were taken into account. Records of patients diagnosed 
with lichenoid lesions were excluded from the sample. 
In particular, we excluded patients with oral lichenoid 
contact lesions (OLCL) resulting from allergic contact 
stomatitis (delayed immune mediated hypersensitivity), 
most commonly in direct topographic relationship to 
dental restorative materials (5), and patients with oral 
lichenoid drug reactions (OLDR), which arise in tem-
poral association with the use of some medications (e.g. 
oral hypoglycaemic agents, angiotensin-converting en-
zyme inhibitors) (8).
For the clinical classification, we used the modified 
WHO criteria proposed by van der Meij  and  van der 
Waal (9). Only patients with clinical and histological 
evidence of OLP were included in the study. Incomplete 
or inaccurate records (256/889, 32%) were not consid-
ered. The final sample thus consisted of 633 records.
Results
Data were obtained from the medical records of 633 pa-
tients with clinically and histopathologically confirmed 
diagnoses of OLP. Most (498/633, 78.67%) OLP patients 
were female. The mean age at presentation was 52 years 
among women and 64 years among men. The major-
ity (52%) of patients were referred by general dentists. 
General medical practitioners (family physicians) re-
ferred 24% of the OLP patients and nearly 21% of pa-
tients sought consultation spontaneously. 
The white type of the disease (reticular/papular/plaque 
lesions) was the main form encountered in this sam-
ple (310/633, 48.97%), (Figs. 1,2). The ulcerative form 
of OLP was observed in 35.86% of patients (227/633). 
Atrophic-erosive lesions were observed in 13.59% of 
patients (86/633), sometimes concomitantly with reticu-
lar lesions. The bullous form of OLP was observed in 
only 10 patients (Table 1).
Fig. 1. Reticular white lesions on the left buccal mucosa of a male 
patient.
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Fig. 2. Lingual involvement of the same patient of Figure 2.
Table 1. Clinical presentation and symptoms in 633 OLP patients.
?
Clinical aspect N° of cases 
(%) 
Symptoms No symptoms 
Reticular/papular/plaque lesions 310/633
(48.9) 
88 222
Ulcerative lesions 227/633
(35.8) 
209 18
Atrophic/erosive lesions 86/633
(13.5) 
71 15
Bullous lesions 10/633
(1.5) 
2 8
Among all 633 patients, the buccal mucosa was the most 
common site of involvement, followed by the tongue, 
gingiva, labial mucosa, and floor of the mouth. Lesions 
on the palate were observed rarely.
The majority (58%) of patients reported at least one 
symptom, and atrophic-erosive lesions and ulcerative 
forms were associated with significantly more symp-
tom-related complaints (e.g. pain, burning sensation, 
bleeding), (Table 1).
Almost 25% of patients had skin involvement, as con-
firmed by a senior dermatologist who evaluated the med-
ical records (MT). In particular, 130 patients showed the 
typical skin lesions (shiny, violaceous, flat-topped, po-
lygonal papules, sometimes with fine white Wickham’s 
striae). Few patients had scalp or nail involvement (2% 
of patients). Again, lesions of the oral mucosa were rare-
ly associated with those of the genital mucosa (2% of 
patients). In 3 patients only were reported oesophageal 
involvement.  
Major stress (e.g. death in family, divorce, job loss, major 
accident) was a factor in 26.26% (151/633) of patients.
Liver profiles including serum transaminase levels, to-
tal bilirubin, antibodies to hepatitis B and C viruses (the 
latter available regularly only after 1995, obtained using 
ELISA with standardised reagents), and hepatitis B sur-
face antigen showed that 24% (179/633) of patients were 
affected by liver abnormalities. In particular, 9.64% 
(61/456) of patients with available hepatitis C virus 
(HCV) test results were HCV serum-positive.
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Table 2. Characteristics of OLP patients with malignant development.
Patient Gender Age
(at malignant 
transformation)
General 
diseases
OLP clinical 
forms
Tobacco 
usage
Daily alcohol 
consumption 
ED Female 67 none Erosive < 1 pack 
daily
None
GV Female 70 Diabetes, 
hypertension 
Erosive None None
IP Male 77 Pulmonary 
tuberculosis, 
Hypertension 
Erosive > 1 pack 
daily
5 units daily 
CM Male 70 HCV-related 
liver disease, 
cholelithiasis 
Erosive < 1 pack 
daily
None
GM Female 69 Atrial
fibrillation, 
hypertension 
Reticular None None
ES Female 63 None Erosive None 3 units daily 
?
OLP was associated with gallbladder diseases in 19% 
(121/633) of patients. Such diseases consisted mainly of 
cholecystitis, cholelithiasis (gallstones), and abscesses, 
with a few cases of sclerosing cholangitis and tumours. 
Diabetes mellitus, mainly type 2, affected 10% of OLP 
patients.
Six patients (0.95%) developed squamous cell carcino-
ma at a site with confirmed OLP lesions (Table 2). All 
but one malignant transformation occurred in erosive or 
erythematous types of lichen planus, with no dysplasia 
reported in initial biopsies. One malignant transforma-
tion arose in a reticular form of OLP.
Discussion
The clinical characteristics of the patients studied in 
this cohort were similar to those reported in the litera-
ture. The predominance of OLP in female patients and 
in those in the fifth through seventh decades of life was 
observed in the present study, in agreement with other 
reports (10-12).
The buccal mucosa was the most common site of OLP 
lesions in our sample, which is similar to the findings of 
previous reports (10-13).
The white type of OLP (reticular/papular/plaque lesions) 
was predominant in this Romanian sample (48.97% of 
633 patients), in agreement with three reports from 
Croatia that found white forms of OLP in 66.9% (14), 
88.5% (15), and 62% (16) of patients considered. Simi-
lar results were also observed in an Iranian sample (77% 
keratotic forms), (17) although the authors found a higher 
prevalence of OLP in the third to fourth decades of life 
(mean age: 41.6 years). This age distribution differs from 
that in our Romanian patients, in which OLP occurred at 
a mean age of 52 years in women and 64 years in men.
In a study of Croatian patients (14), OLP was found to be 
associated most commonly with hepatobiliary diseases 
(cholecystopathy, cholelithiasis, increased bilirubin 
value). Liver disease (including hepatitis and cirrhosis) 
was also detected in a group of Croatian OLP patients 
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(42/175, 24%), (16). In our sample, 19% of OLP patients 
had gallbladder diseases, represented mainly by chole-
cystitis and cholelithiasis (gallstones). Compared with 
the general Romanian population, OLP patients had 
a higher prevalence of gallbladder diseases (19% vs. 
8.4%), (18).
In our sample, 9.6% of patients were HCV serum-po-
sitive. Epidemiological data suggest that LP may be as-
sociated significantly with HCV infection in Southern 
Europe and Japan, but not in northern Europe. This 
geographical difference may be due to immunogenetic 
factors, duration of HCV infection, and differences in 
study design (19). A recent nationwide cross-sectional 
survey (20) conducted from 2006–2008 using popu-
lation-stratified, random cluster sampling found HCV 
infection in 3.23% of the Romanian adult population. 
Anti-HCV circulating antibodies thus appear to be 
more common in patients with OLP than in the general 
population.
Diabetes mellitus, mainly type 2, affected 10% of the 
OLP patients in our sample, reflecting the prevalence 
of diabetes (types 1 and 2) in the general population of 
Romania (8–9%), (21).
OLP is considered to be a potentially malignant disor-
der of the oral mucosa (22). The most important com-
plication of this disease may be the development of oral 
squamous carcinoma, although this is a very controver-
sial topic (23). In our sample, six patients (0.95%) devel-
oped squamous cell carcinoma at a site with confirmed 
OLP lesions. Five malignant transformations occurred 
in erosive or atrophic types of lichen planus, with no 
dysplasia noted in initial biopsies, and one malignant 
transformation arose in a reticular form of OLP. This 
percentage is rather similar to other reported data. A 
study in south-eastern Spain (13) found a maligniza-
tion rate of 0.90% (8/550 OLP patients). Carbone et al. 
(24) reported that 1.85% of 808 OLP patients in Italy 
developed oral carcinoma during the follow-up period. 
Thirteen of 690 (1.9%) British OLP patients (11) devel-
oped oral squamous carcinoma and four of 141 (2.8%) 
patients in Switzerland (25) showed oral carcinoma at 
a site with OLP lesions. Given that chronic inflamma-
tion has been associated causally with various types of 
cancer, the malignant transformation of OLP may be re-
lated to, or dependent on, a series of molecular stimuli 
originating in the inflammatory infiltrate (e.g. cytokine 
and chemokine release by infiltrating T cells). These 
stimuli may induce fundamental protein changes in oral 
epithelial cells, leading to the progression of OLP to 
oral squamous cell carcinoma (26).
In this cohort, 26% of patients reported an exacerba-
tion of OLP symptoms in periods of greater emotional 
tension and/or anxiety. In a recent paper, Manolache 
and colleagues (27) evaluated the possible role of stress 
in the onset/extension of cutaneous lichen planus in 
patients treated at the dermatological department of 
Cetatea Histria Polyclinic in Bucharest, Romania. In 
this case-control study, the authors identified at least 
one potentially stressful situation in 31 cases (67.39%), 
compared with the occurrence of such situations in 10 
control patients (21.73%). Psychological disturbances 
have been investigated in the etiopathogenesis of OLP. 
Stress, as well as other psychological alterations, seems 
to modify and promote dysregulation of immune func-
tions by altering the Th1/Th2 cytokine balance and in-
creasing Th2 response, which is associated with the de-
velopment of autoimmune diseases (28). Although some 
investigations (29,30) have failed to replicate the associ-
ation between OLP and stressful events, psychological/
psychiatric services should be combined with conven-
tional therapy for these patients to avoid the occurrence 
of somatisation and to prevent disease exacerbation.
Although observational retrospective studies have vari-
ous limitations, to the best of our knowledge, no similar 
study has been conducted in a Romanian population. 
The present investigation revealed the predominance of 
OLP among middle-aged white women and the preva-
lence of bilateral involvement of the buccal mucosa. 
Reticular lesions were most frequent, followed by the 
erosive form, which is most frequently associated with 
painful symptoms. Anti-HCV circulating antibodies 
were more common in patients with OLP than in the 
general population and, notably, OLP was associated 
with gallbladder disease (cholecystitis, cholelithiasis) in 
19% of patients.
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